Bio-thera Solutions, Ltd. Class ASSE: 688177

Announcement on Adjusting the Development Strategy of BAT3306 (Pembrolizumab)

· Issued by Bio-thera Solutions, Ltd. Class A via Shanghai Stock Exchange
Announcement on Adjusting the Development Strategy of BAT3306 (Pembrolizumab)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment